| Title | Design and synthesis of boron containing potential pan-RAR inverse agonists. |
| Publication Type | Journal Article |
| Year of Publication | 2012 |
| Authors | Das BC, Tang X-Y, Evans T |
| Journal | Tetrahedron Lett |
| Volume | 53 |
| Issue | 11 |
| Pagination | 1316-1318 |
| Date Published | 2012 Mar 14 |
| ISSN | 0040-4039 |
| Abstract | <p>We designed and successfully synthesized the compounds 5 and 8 as potential pan-RAR (retinoic acid receptor) agonists. These two compounds were designed based on an existing pan-RAR agonist (BMS493). We synthesized compound 5, in which the carboxylic acid group in BMS 493 was replaced by boronic ester; and compound 8, in which the double bond of BMS 493 was changed to an oxadiazole (as bioisosteres of double bond) ring. The two target molecules 5 and 8 were synthesized from the commercially available 7-bromo-4,4-dimethyl-3,4-dihydronaphthalen-1(2H)-one 1. Compound 1 was derivatized to intermediate 5,5-dimethyl-8-(phenylethynyl)-5,6-dihydronaphthalene-2 carbaldehyde 4 by using alkylation, dehydration, and metal exchange reactions. The intermediate 4 was further converted to 5 by using a Wittig reaction and to 8 by amide coupling and dehydration to give overall 18% and 33% yields, respectively, after 8 steps in each case.</p> |
| DOI | 10.1016/j.tetlet.2011.12.118 |
| Alternate Journal | Tetrahedron Lett |
| PubMed ID | 23180890 |
| PubMed Central ID | PMC3505081 |
| Grant List | R01 HL056182 / HL / NHLBI NIH HHS / United States R21 AA020630 / AA / NIAAA NIH HHS / United States R37 HL056182 / HL / NHLBI NIH HHS / United States R56 AI093220 / AI / NIAID NIH HHS / United States |